The 24 linked references in paper O. Voronina L., M. Kunda S., N. Ryzhova N., E. Aksenova I., A. Semenov N., A. Lazareva V., S. Semykin Yu., E. Amelina L., O. Simonova I., S. Krasovskiy A., V. Lunin G., A. Baranov A., A. Chuchalin G., A. Gintsburg L., О. Воронина Л., М. Кунда С., Н. Рыжова Н., Е. Аксенова И., А. Семенов Н., А. Лазарева В., С. Семыкин Ю., Е. Амелина Л., О. Симонова И., С. Красовский А., В. Лунин Г., А. Баранов А., А. Чучалин Г., А. Гинцбург Л. (2015) “Разнообразие и опасность Achromobacter spp., поражающих дыхательные пути больных муковисцидозом // Diversity and hazard of respiratory infection of Achromobacter spp. in cystic fibrosis patients” / spz:neicon:pulmonology:y:2015:i:4:p:389-402

  1. Mahenthiralingam E. Emerging cystic fibrosis pathogens and the microbiome.Paediatr. Respir. Rev.2014; 15 (Suppl. 1): 13–15. DOI: 10.1016/j.prrv.2014.04.006.
  2. Vandamme P., Moore E.R., Cnockaert M. et al. Clas\n sification of Achromobacter genogroups 2, 5, 7 and 14 as Achromobacter insuavis sp. nov., Achromobacter aegrifa\n ciens sp. nov., Achromobacter anxifer sp. nov. and Achro\n mobacter dolens sp. nov., respectively. Syst. Appl. Microbiol. 2013; 36 (7): 474–482. DOI: 10.1016/j.syapm. 2013.06.005.
  3. Vandamme P., Moore E.R., Cnockaert M. et al. Achromobacter animicus sp. nov., Achromobacter muci\n colens sp. nov., Achromobacter pulmonis sp. nov. and Achromobacter spiritinus sp. nov., from human clinical samples. Syst. Appl. Microbiol. 2013; 36: 1–10. DOI: 10.1016/j.syapm.2012.10.003.
  4. Klinger J.D., Thomassen M.J. Occurrence and antimicro\n bial susceptibility of gram\nnegative nonfermentative bacilli in cystic fibrosis patients. Diagn. Microbiol. Infect. Dis. 1985; 3: 149–158. DOI:10.1016/0732\n8893(85)90025\n2.
  5. Spilker T., Vandamme P., Lipuma J.J. Identification and distribution of Achromobacter species in cystic fibrosis. J. Cyst. Fibros.2013; 12 (3): 298–301. DOI: 10.1016/j.jcf.
  6. Zhang Z., Fan X., Gao X., Zhang X.H. Achromobacter sediminum sp. nov., isolated from deep subseafloor sedi\n ment of South Pacific Gyre. Int. J. Syst. Evol. Microbiol. 2014; 64 (Pt 7): 2244–2249. DOI: 10.1099/ijs.0.062265\n0.
  7. Magni A., Trancassini M., Varesi P. et al. Achromobacter xylosoxidans genomic characterization and correlation of randomly amplified polymorphic DNA profiles with rele\n vant clinical features [corrected] of cystic fibrosis patients. J. Clin. Microbiol.2010; 48 (4):1035–1039. DOI: 10.1128/ JCM.02060\n09.
  8. Trancassini M., Iebba V., CiteràN. et al. Outbreak of Achro\n mobacter xylosoxidans in an Italian Cystic fibrosis center: genome variability, biofilm production, antibiotic resistance, and motility in isolated strains. Front. Microbiol. 2014; 5: 138. DOI: 10.3389/fmicb.2014.00138. eCollection 2014.
  9. Wang M., Ridderberg W., Hansen C.R. et al. Early treat\n ment with inhaled antibiotics postpones next occurrence of Achromobacter in cystic fibrosis. J. Cyst. Fibros. 2013; 12: 638–643. DOI: 10.1016/j.jcf.2013.04.013.
  10. Barrado L., Brañas P., Orellana M.Á. et al. Molecular characterization of Achromobacter isolates from cystic fibrosis and non\ncystic fibrosis patients in Madrid, Spain. J. Clin. Microbiol. 2013; 51: 1927–1930. DOI: 10.1128/JCM. 00494\n13.
  11. Traglia G., Papalia M., Almuzara M. et al. Presence of OXA\ntype enzymes in Achromobacter insuavis and A. dolens. Curr. Microbiol. 2014; 69 (4): 501–506. DOI: 10.1007/s00284\n014\n0611\ny.
  12. Pereira R.H., Carvalho\nAssef A.P., Albano R.M. et al. Achromobacter xylosoxidans: characterization of strains in Brazilian cystic fibrosis patients. J. Clin. Microbiol.2011; 49 (10): 3649–3651. DOI: 10.1128/JCM.05283\n11.
  13. Dupont C., Michon A.L., Jumas\nBilak E. et al. Intrapatient diversity of Achromobacter spp. involved in chronic colo\n nization of Cystic Fibrosis airways. Infect. Genet. Evol. 2015; 32: 214–223. doi: 10.1016/j.meegid.2015.03.012
  14. Papalia M., Almuzara M., Cejas D. et al. OXA\n258 from Achromobacter ruhlandii: a species\nspecific marker. J. Clin. Microbiol.2013; 51 (5): 1602–1605. DOI: 10.1128/JCM. 03043\n12.
  15. Ridderberg W., Wang M., Nørskov\nLauritsen N. Multilocus sequence analysis of isolates of Achromobacter from patients with cystic fibrosis reveals infecting species other than Achromobacter xylosoxidans.J. Clin. Microbiol. 2012; 50 (8): 2688–2894. DOI: 10.1128/JCM.00728\n12.
  16. Green H., Jones A.M. The microbiome and emerging pathogens in cystic fibrosis and non\ncystic fibrosis bronchi\n ectasis. Semin. Respir. Crit. Care Med.2015; 36 (2): 225–235. DOI: 10.1055/s\n0035\n1546752.
  17. Воронина О.Л., Кунда М.С., Аксенова Е.И. и др. Экспресс диагностика микроорганизмов, поражающих дыхательные пути больных муковисцидозом. Клиническая лабораторная диагностика. 2013; 11: 53–58.
  18. Voronina O.L., Kunda M.S., Ryzhova N.N. et al. The vari\n ability of the order Burkholderiales representatives in the Healthcare Units. BioMed. Res. Int.2015; 2015: 680210. DOI:10.1155/2015/68021.
  19. The Main Site EUCAST. http://www.eucast.org/
  20. Delgado S., Arroyo R., Jiménez E. et al. Staphylococcus epi\n dermidis strains isolated from breast milk of women suffering infectious mastitis: potential virulence traits and resistance to antibiotics. BMC Microbiol.2009; 9: 82. DOI: 10.1186/1471\n 2180\n9\n82.
  21. Spilker T., Baldwin A., Bumford A. et al. Expanded multilo\n cus sequence typing for Burkholderia species. J. Clin. Microbiol.2009; 47 (8): 2607–2610. DOI: 10.1128/JCM. 00770\n09.
  22. Turton J.F., Mustafa N., Shah J. et al. Identification of Achromobacter xylosoxidans by detection of the bla(OXA\n 114\nlike) gene intrinsic in this species. Diagn. Microbiol. Infect. Dis. 2011; 70 (3): 408–411. DOI: 10.1016/j.diagmi\n crobio.2011.02.007.
  23. Amoureux L., Bador J., Fardeheb S. et al. Detection of Achromobacter xylosoxidans in hospital, domestic, and out\n door environmental samples and comparison with human clinical isolates. Appl. Environ. Microbiol.2013; 79 (23): 7142–7149. DOI: 10.1128/AEM.02293\n13.
  24. Воронина О.Л., Кунда М.С., Рыжова Н.Н. и др. Законо\n мерности селекции полигостальных убиквитарных микроорганизмов на примере представителей трех так\n сонов. Молекулярная биология. 2015; 49 (3): 430–441, DOI: 10.7868/S0026898415030179.